# A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia

> **NCT01952041** · NA · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 149 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **BEHAVIORAL:** Device: Smartphone
- **BEHAVIORAL:** Treatment as usual

## Key facts

- **NCT ID:** NCT01952041
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-13
- **Primary completion:** 2017-08-07
- **Final completion:** 2017-08-07
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01952041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01952041, "A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01952041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*